Two clinicians can both be well trained in addiction treatment and hold different starting assumptions about what a good outcome is. One holds sustained abstinence as the goal and works steadily toward it. The other holds that any reduction in harm is a legitimate outcome, and that keeping the door open matters more than setting a threshold at the start.
Neither position is fringe. Both have evidence and serious clinicians behind them. But a mismatch between your goal and your clinician's model is a common and avoidable reason treatment goes nowhere — and it is easy to detect in a single question before you start.
What each model holds
Abstinence-based
Continued use is understood as the central problem, and treatment is organized around stopping and staying stopped. Often, though not always, connected to twelve-step frameworks. Structured, clear about the goal, and well suited to people who have already decided abstinence is what they want — particularly where physical dependence is severe or the consequences of any use are high.
Harm reduction
Any positive change counts: using less, using more safely, using less often, or not at all. The model prioritizes staying engaged with care over meeting a threshold. It originated in public health responses to bloodborne infection and overdose, and now covers naloxone distribution, safer use practices, drug checking, and moderation-oriented goals for alcohol.
In practice, most clinicians blend
Many experienced providers hold harm reduction as a starting stance while working actively toward abstinence where the client wants it, or where continued use is life-threatening. That flexibility is usually a strength. The question is whether they can describe their position clearly rather than whether they sit at one pole.
Harm reduction interventions have strong public health evidence: syringe services programs reduce HIV and hepatitis C transmission without increasing drug use, and naloxone distribution reduces overdose deaths. Retention in care is consistently better when clients are not required to achieve abstinence before receiving services.
Abstinence also has robust support as a goal for those who choose it, particularly in severe alcohol and opioid use disorder. Meanwhile, controlled-drinking outcomes are well documented in the alcohol literature for people with less severe use — the Sobell studies and subsequent work established that moderation is achievable for a substantial subgroup, which is why blanket claims that abstinence is the only possible outcome are not accurate for every presentation.
Why matching matters
The most common mismatch is a client with a moderation goal entering an abstinence-focused program. When the goals do not line up, it becomes harder to speak freely about actual use — and accurate information is what any clinician needs in order to help. Naming your goal at the outset keeps that channel open.
The reverse mismatch happens too. Someone who has decided firmly on abstinence, and who needs structure and accountability, can find a purely non-directive harm reduction stance frustratingly permissive. If you want a clinician who will hold a firm line with you, say so — and confirm that they will.
Where the models converge
Some things hold regardless of model. Overdose prevention — naloxone on hand, not using alone, awareness of reduced tolerance after any period of abstinence — is not a philosophical position, and it is covered across settings, including abstinence-based ones, because risk peaks after a period away from use.
Similarly, motivational interviewing is used across both models, medication is supported by evidence regardless of framework, and co-occurring mental health conditions need treatment either way.
Ask before the first session
- "Do you work from a harm reduction model, an abstinence-based model, or a blend?"
- "Would you work with me if my goal is reducing rather than stopping?"
- "What happens if I use during treatment — do I get discharged?"
- "How do you handle overdose prevention and naloxone?"
- "What is your position on medication for addiction?"
- "If my goal changes during treatment, how do you handle that?"
The discharge question is a practical one. Some programs terminate for continued use. That is a legitimate policy, and it is one you should know about in advance rather than discover at the point it applies to you.
- Providers work from different models, and both have real evidence behind them.
- A mismatch makes it harder to speak freely about use — and that openness is what treatment runs on.
- Ask about the model, and about what happens if you use during treatment.
- Overdose prevention is not model-dependent — it is covered across settings.
- Most experienced clinicians blend; the point is that they can describe their position.
References
- Marlatt, G. A., Larimer, M. E., & Witkiewitz, K. (Eds.). (2011). Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors (2nd ed.). Guilford Press.
- Aspinall, E. J., et al. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs? International Journal of Epidemiology, 43(1), 235–248.
- Sobell, M. B., & Sobell, L. C. (1995). Controlled drinking after 25 years: How important was the great debate? Addiction, 90(9), 1149–1153.
- Substance Abuse and Mental Health Services Administration. Harm Reduction Framework. Retrieved from samhsa.gov.